| Systematic (IUPAC) name | |
|---|---|
| (2S,4aR,6aR,7R,9S,10aS,10bR)- 9-(methoxymethoxy)- 2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho-[2,1-c]pyran-7-carboxylic acid methyl ester | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Legal/Uncontrolled |
| Identifiers | |
| ATC code | None |
| PubChem | CID 11407876 |
| ChemSpider | 23323947 |
| ChEMBL | CHEMBL258098 |
| Chemical data | |
| Formula | C23H30O8 |
| Mol. mass | 434 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
2-Methoxymethyl salvinorin B is a semi-synthetic analogue of the natural product salvinorin A which is used in scientific research.[1][2] It has a longer duration of action of around 2–3 hours, compared to less than 30 minutes for salvinorin A,[3] and has increased affinity and efficacy at the κ-opioid receptor. Like the related compound herkinorin, 2-methoxymethyl salvinorin B is made from salvinorin B, which is most conveniently made from salvinorin A by deacetylation,[4] as while both salvinorin A and salvinorin B are found in the plant Salvia divinorum, salvinorin A is present in larger quantities.[5]
2-Methoxymethyl salvinorin B has a Ki of 0.60 nM at the κ opioid receptor,[6] and is around 5x more potent than Salvinorin A in animal studies, although it is still only half as potent as its stronger homologue 2-Ethoxymethyl Salvinorin B.[7]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)